March 2nd 2022
This Uroview features discussion between Dr. Alexandra Rogers and Dr. Scott MacDiarmid about current and emerging treatments for overactive bladder, with a focus on implantable tibial nerve stimulation devices in this space.
January 21st 2022
Expert perspectives on the use of saw palmetto extracts to manage patients with benign prostatic hyperplasia and lower urinary tract symptoms.
Robert Dreicer, MD, provides an overview of advances in the treatment of metastatic castration-resistant prostate cancer (mCRPC) and available and emerging second-line treatment options for mCRPC.
December 22nd 2021
Steven Finkelstein, MD, DABR, FACRO, and Louis J. Mazzarelli, MD, react to the article, “A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT,” by Pernthaler B, et al.
October 14th 2021
June 30th 2021
Kyle Wood, MD, reviews currently available treatment options for enteric hyperoxaluria and the importance of disease education.
June 10th 2021
Two experts in urology provide a discussion on currently available screening and risk assessment tools in prostate cancer and emphasize the importance of early detection.
May 14th 2021
Analysis of Gallium-68 PSMA 9 (prostate-specific membrane antigen) targeted PET (positron emission tomography) imaging and its impact on staging and prostate cancer.
April 23rd 2021
Brad Schwartz, DO, FACS, comments on newer urologic imaging techniques that can reduce exposure to radiation.
January 8th 2021
Specialists in urology discuss the significance of germline testing in prostate cancer.
